FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Ajanta Pharma USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Montelukast Sodium (generic montelukast) submitted by Ajanta Pharma USA Inc. under ANDA203328.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Exercise-induced Bronchoconstriction
• Seasonal Allergic Rhinitis

Drugs mentioned

• Montelukast Sodium (Montelukast Sodium)

Snippet

SUPPL AP for MONTELUKAST SODIUM (MONTELUKAST SODIUM)